Results 21 to 30 of about 8,104 (211)

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis [PDF]

International Journal of COPD, 2015
David MG Halpin,1 Ronald Dahl,2 Christoph Hallmann,3 Achim Mueller,3 Donald Tashkin4 1NHS SW, Royal Devon and Exeter Hospital, Exeter, Devon, England, UK; 2Allergy Centre, Odense University Hospital, Odense, Denmark; 3Boehringer Ingelheim Pharma GmbH ...
Halpin DMG, Dahl R, Hallmann C, Mueller A, Tashkin D   +4 more
doaj   +2 more sources

Tiotropium HandiHaler® in the treatment of COPD: A safety review

International Journal of COPD, 2009
Steven Kesten1, Bart Celli2, Marc Decramer3, Inge Leimer4, Donald Tashkin51Boehringer Ingelheim Pharmaceuticals; Ridgefield, CT, USA; 2Caritas St. Elizabeth’s Medical Center, Boston, MA, USA; 3University of Leuven, Leuven, Belgium; 4Boehringer ...
Steven Kesten, Bart Celli, Marc Decramer, et al   +3 more
doaj   +1 more source

Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients

International Journal of COPD, 2012
Kenji Yoshimura, Ryoji Maekura, Toru Hiraga, Seigo Kitada, Keisuke Miki, Mari Miki, Yoshitaka TateishiDepartment of Respiratory Medicine, Toneyama National Hospital, Osaka, JapanBackground: Tiotropium partially relieves exertional dyspnea and reduces the
Kitada S, Hiraga T, Maekura R, Yoshimura K, Tateishi Y, Miki M, Miki K   +6 more
doaj   +1 more source

Anti-inflammatory effects of tiotropium in COPD: a randomised double-blind trial [PDF]

ERJ Open Research
Background COPD is a major global health issue characterised by respiratory symptoms and exacerbations, significantly impacting mortality and quality of life.
Lisa H. van Smoorenburg, Tatiana Karp, Benedikt Ditz, Wouter H. van Geffen, Victor Guryev, Ali Almusa, Loes Kistemaker, Reinoud Gosens, Maarten van den Berge, Huib A.M. Kerstjens   +9 more
doaj   +2 more sources

UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD

ClinicoEconomics and Outcomes Research, 2016
Abigail Tebboth,1 Andrew Ternouth,1 Nuria Gonzalez-Rojas2 1Boehringer Ingelheim Ltd., Bracknell, UK; 2Boehringer Ingelheim GmBH, Ingelheim, Germany Objective: The aim of this study is to assess the cost-effectiveness of other long-acting muscarinic ...
Tebboth A, Ternouth A, Gonzalez-Rojas N
doaj   +1 more source

Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease [PDF]

, 2012
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Christopher J Cates, Karner, C, Cates, CJ, Charlotta Karner   +3 more
core   +1 more source

Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease (Review) [PDF]

, 2011
Background The long-acting bronchodilator tiotropium and single inhaler combination therapy of inhaled corticosteroids and long-acting beta(2)-agonists are both commonly used for maintenance treatment of chronic obstructive pulmonary disease.
Christopher J Cates, Karner, C, Cates, CJ, Charlotta Karner   +3 more
core   +1 more source

Tiotropium in asthma: a systematic review [PDF]

Journal of Asthma and Allergy, 2014
Elizabeth Befekadu,1 Claudia Onofrei,1 Gene L Colice1,2 1MedStar Washington Hospital Center, Washington, DC, USA; 2The George Washington University School of Medicine and Health Sciences, Washington, DC, USA Introduction: The objective of this paper is ...
Befekadu E, Onofrei C, Colice GL
doaj   +1 more source

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease (Review) [PDF]

, 2011
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Christopher J Cates, Karner, C, Cates, CJ, Charlotta Karner   +3 more
core   +1 more source

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease [PDF]

, 2010
Background Combination therapy (inhaled corticosteroids and long-acting beta(2)-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD).
Christopher J Cates, Emma J Welsh, Welsh, EJ, Phillippa Poole, Cates, CJ, Poole, P   +5 more
core   +1 more source